A federal jury ruled that Johnson & Johnson must pay $247 million to settle claims that it failed to warn doctors and patients about possible defects with its Pinnacle artificial hips. J&J plans to appeal the ruling.
Auxilium, a unit of Endo International, is not liable for a heart attack suffered by a man who was taking the company's testosterone replacement drug Testim, a federal jury ruled last week. Endo is facing more than 1,200 other lawsuits involving Testim.
A UK study found men with stereotypically male gender traits, such as being aggressive or competitive, may skew research results because they are more likely to volunteer for pain studies. Researchers said this could affect study demographics and how scientists interpret differences between men and women.
An international team of researchers found the pain-sensing receptor TRPV1 binds with the hormone oxytocin to suppress pain. The findings could aid in the development of new, nonaddictive pain medications.
Battle Ground HealthCare's Take Back My Life pain management program in Clark County, Wash., uses occupational and physical therapy, dietary, and mental health strategies as alternatives to pain medications. An analysis of 58 people in the program found they had significant improvement in physical function, anxiety, depression, fatigue, satisfaction in social roles and pain interference.
Vioxx, or rofecoxib, a drug shelved by Merck & Co. in 2004 because data showed it doubled the risk of stroke or heart attack, could be brought back by Tremeau Pharmaceuticals as a potential treatment for hemophilia patients with severe joint pains.
APS will hold its Annual Scientific Meeting in the form of a Scientific Summit March 4-6, 2018, with a balance of clinical, translational, and basic science research around a central theme: Understanding Pain Mechanisms. Register by December 1 for a chance to win a free hotel night at the Disneyland® Hotel! Learn more.
If you are a junior investigator planning a clinical research study you are invited to submit a summary of proposed research to the ACTTION-APS workshop! This is a great opportunity to obtain constructive feedback to improve research design and execution, and a chance to receive a $1,250 honorarium to support attendance of the APS Scientific Summit in Anaheim. Submit your proposal before November 30 for a chance to be selected as a workshop participant! Learn more.
David Loxterkamp, M.D., writes in the Annals of Family Medicine about coping after two physicians left his practice and he found it difficult to fill the void. Loxterkamp re-evaluated recent changes to the recently expanded practice and found they had led to isolation, so he developed strategies to engage his medical team and foster well-being.
Researchers found 68.8% of residents at three northern California nursing homes were eligible for palliative care, but none were receiving it and only two were in hospice. The study in JAMA Internal Medicine found 98.7% of the residents had a Physician Order for Life-Sustaining Treatment directive.